Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 10,000 shares at $28.00 ($280K) on 2014-06-12, disclosed to the SEC on 2014-06-16.
Scheduled sale ($280k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |